This study is in progress, not accepting new patients
An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
a study on Hemophilia
Hemophilia A prophylaxis treatment Hemophilia episodic treatment Factor VIII rFVIIIFc
Lead Scientist at UCSF
- Tiffany Lin
As a faculty member at UCSF Pediatric Hematology/Oncology, I see patients with pediatric hematologic and oncologic disorders although the majority of my time is spent in hematologic diseases such as patients with bleeding disorders, thromboses, immune cytopenias or aplastic anemia, bone marrow failure syndromes, and more.
- in progress, not accepting new patients
- Start Date
- Completion Date
- Bioverativ Therapeutics Inc.
- Phase 3
- Study Type
- Last Updated